Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
about
Small intestinal bacterial overgrowth syndromeSystemic Sclerosis and the Gastrointestinal Tract-Clinical ApproachPediatric small intestine bacterial overgrowth in low-income countries.Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance.Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndromeRifaximin pharmacology and clinical implications.Breath Hydrogen Gas Concentration Linked to Intestinal Gas Distribution and Malabsorption in Patients with Small-bowel Pseudo-obstruction.Small intestinal bacterial overgrowth in systemic sclerosis.Management of gastrointestinal involvement in scleroderma.Diagnosis and treatment of small intestinal bacterial overgrowth.Current management of the gastrointestinal complications of systemic sclerosis.Systemic sclerosis--challenges for clinical practice.Review article: small intestinal bacterial overgrowth--prevalence, clinical features, current and developing diagnostic tests, and treatment.Distinguishing between limited systemic scleroderma-associated pseudo-obstruction and peritoneal disseminationThe Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review.Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth.Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.Association of Systemic Sclerosis With a Unique Colonic Microbial Consortium.Gastrointestinal complications of systemic sclerosis.Microflora modulation of motility.Gastrointestinal motility disorder assessment in systemic sclerosis.Response to Paterson et al.Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients.Measurement of oro-caecal transit time by magnetic resonance imaging.
P2860
Q24262889-3C45A93E-BC47-4941-A64E-740DDEEBF802Q28079598-8D954D72-3660-48F3-8AF9-97535934E697Q30301148-EF0C3CC0-2854-4B56-9ED6-ABF8A3435E60Q33459081-D64641F8-005F-4BAC-82CC-D142E6D9B4A6Q33463153-7902258D-E084-4D7F-9B8B-E7B53F823363Q34607677-A150E34B-55E1-4E58-BACD-DC02D7E195B9Q34610491-6B8A5B7D-F1B3-4761-9548-A1B700755CF9Q34611011-9ABB3C15-FFAD-448F-8CF1-A9D1EE3A98E2Q35624333-26108970-CEA1-4F7A-8F87-8B0EB5E1EB52Q35860893-FB2E3093-3EA7-4A29-8B1C-691F37648C6EQ36068493-5C75F8CF-0F97-40D2-B343-9D240DA0FDECQ38059459-B4B165D7-E735-4708-B725-11E6F237DD63Q38129946-DF3838C5-DC77-491B-B76C-A4A73B5E425AQ38326760-E64F7B31-24FA-41A2-822E-79EFAD2272CFQ38611012-BE45B337-7A9D-40A1-8184-7CAA66008726Q39081757-34EB440F-4057-4DF0-9761-51285A8C2F40Q39129418-D397AE4C-11D9-4373-902F-ECCCBF924844Q40125404-31B8C9D1-61CE-49C1-A4F9-B7F274C155C8Q42176643-BF9F4A16-43EC-48BA-9889-6B9EFB364175Q42732314-0C79F2DA-138E-459A-8047-3CA3D3C55C87Q43575031-9A539A58-A265-4BBC-B5FE-6C00ABBF7A2DQ45981201-6FCCE85A-D059-4515-A558-CAA9C3F79B5CQ46476404-DEFF6CE9-2D23-4D96-A54C-839D7A979A89Q51462731-E9B27804-34EA-4FC5-895E-510EF12CB524Q51667996-1A9FC832-F7AF-40E9-A686-581024F8113F
P2860
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Small intestinal bacterial ove ...... ectiveness of its eradication.
@en
Small intestinal bacterial ove ...... ectiveness of its eradication.
@nl
type
label
Small intestinal bacterial ove ...... ectiveness of its eradication.
@en
Small intestinal bacterial ove ...... ectiveness of its eradication.
@nl
prefLabel
Small intestinal bacterial ove ...... ectiveness of its eradication.
@en
Small intestinal bacterial ove ...... ectiveness of its eradication.
@nl
P2093
P2860
P1476
Small intestinal bacterial ove ...... fectiveness of its eradication
@en
P2093
Alfredo Greco
Andrea Parodi
Edoardo Savarino
Francesco Indiveri
Marco Bazzica
Marta Sessarego
Massimo Ghio
Maurizio Setti
Vincenzo Savarino
P2860
P304
P356
10.1111/J.1572-0241.2007.01758.X
P407
P577
2008-04-16T00:00:00Z